GRASPING TIRZEPATIDE AND MOUNJARO: THE COMPREHENSIVE EXPLANATION

Both This medication and this treatment represent innovative approaches to managing glucose control, and increasingly, obesity. Semaglutide is a twin agonist that targets two chemicals involved in metabolism: the incretin hormone and GIP. It, often considered as a brand name for Semaglutide, acts